Literature DB >> 21535319

Increasing body weight enhances prevalence and proximal extent of reflux in GERD patients 'on' and 'off' PPI therapy.

K Blondeau1, V Boecxstaens, L Van Oudenhove, R Farré, G Boeckxstaens, J Tack.   

Abstract

BACKGROUND: Increased body weight is associated with higher intragastric pressure. Proximal extent of reflux is a determinant of symptoms in patients with gastro-esophageal reflux disease (GERD). We aimed to investigate the association between body mass index (BMI) and abdominal circumference on the incidence and proximal extent of reflux.
METHODS: A total of 95 patients [37 men, age 51(16-82) years] with typical and/or atypical GERD symptoms underwent 24 h impedance-pH monitoring. Forty-nine patients were studied 'off' and 46 'on' proton pump inhibitors (PPI) treatment. Reflux was classified as acid (pH < 4) or weakly acidic (pH 4-7). Proximal extent was defined as the number of reflux events reaching ≥15 cm above the lower esophageal sphincter. Body mass index and abdominal circumference (cm) were assessed. KEY
RESULTS: In patients 'off' PPI, there was a correlation between BMI and esophageal acid exposure (ρ = 0.53, P < 0.001), volume exposure (ρ = 0.48, P < 0.001), total number of reflux events (ρ = 0.47, P < 0.001) and number of acid reflux events (ρ = 0.49, P < 0.001). In patients 'on' PPI there was a correlation between BMI and esophageal acid exposure (ρ = 0.32, P = 0.03), volume exposure (ρ = 0.46, P < 0.01) and total number of reflux events (ρ = 0.33, P = 0.03). Similar correlations were found between abdominal circumference and reflux. A correlation between BMI and proximal extent of reflux was present in patients 'off' PPI (ρ = 0.32, P = 0.03). In patients 'on' PPI, we found a correlation between abdominal circumference and proximal extent (ρ = 0.31, P = 0.03). CONCLUSIONS & INFERENCES: Body mass index and abdominal circumference may contribute to GER and its proximal extent, in patients 'on and 'off' PPI. Further studies investigating the role of weight reduction in the control of GERD symptoms are warranted.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21535319     DOI: 10.1111/j.1365-2982.2011.01720.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  4 in total

1.  Evaluations of life style factors and the severity of Gastroesophageal reflux disease; a case-control study.

Authors:  Saba Fakhrieh Asl; Fariborz Mansour-Ghanaei; Hooman Samadi; Farahnaz Joukar
Journal:  Int J Mol Epidemiol Genet       Date:  2015-09-09

Review 2.  Diagnostic yield of ambulatory oesophageal studies on versus off proton pump inhibitors: a systematic review and meta-analysis.

Authors:  Daphne Ang; Qishi Zheng; Luming Shi; Jan Tack
Journal:  United European Gastroenterol J       Date:  2018-04-20       Impact factor: 4.623

3.  The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole.

Authors:  D A Peura; B Pilmer; B Hunt; R Mody; M C Perez
Journal:  Aliment Pharmacol Ther       Date:  2013-03-04       Impact factor: 8.171

4.  Critical analysis of esophageal multichannel intraluminal impedance monitoring 20 years later.

Authors:  Fernando A M Herbella
Journal:  ISRN Gastroenterol       Date:  2012-10-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.